Cirrhotic Cardiomyopathy: Prevalence and Clinical Impact on Liver Cirrhosis Outcomes
CCM is prevalent among Japanese patients with liver cirrhosis and is associated with an increased risk of hepatic decompensation. These findings highlight the importance of cardiac evaluation in patients with cirrhosis and suggest that CCM should be considered in the management of liver cirrhosis to improve patient outcomes.
Authors
- Naohiro Yasuura (ORCID: https://orcid.org/0000-0001-9453-9469)
- Shunichi Hosoda
- Takashi Sasaki (ORCID: https://orcid.org/0000-0002-9245-7854)
- Kôsuke Nakamura (ORCID: https://orcid.org/0000-0002-4225-0804)
- Takako Tanaka (ORCID: https://orcid.org/0000-0003-2998-7200)
- Shunsuke Ohnishi (ORCID: https://orcid.org/0000-0003-1194-4149)
- Naoya Sakamoto (ORCID: https://orcid.org/0000-0003-0061-059X)
- Goki Suda (ORCID: https://orcid.org/0000-0003-0098-9106)
- Qingjie Fu (ORCID: https://orcid.org/0000-0001-7460-8228)
- Masatsugu Ohara (ORCID: https://orcid.org/0000-0002-4366-3184)
- Takashi Kitagataya
- Masato Nakai (ORCID: https://orcid.org/0000-0002-4860-1353)
- Takuya Sho (ORCID: https://orcid.org/0000-0001-7943-3842)
- Risako Kohya (ORCID: https://orcid.org/0000-0002-1516-9314)
- Akimitsu Meno
- Osamu Maehara
- Shoichi Kitano
- Sonoe Yoshida
- Suguru Ishizaka
Institutions
- Hokkaido University of Science (JP)
- Hokkaido University (JP)
- Hokkaido Pharmaceutical University (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1111/hepr.14232
- Citations
- 1
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- Japan Agency for Medical Research and Development